---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-009659"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T09:59:02.029506+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Aditxt extends Evofem merger timeline; proxy statement filing pushed to April 1, 2024

## Summary
- Second Amendment to Merger Agreement extends Parent Loan to Evofem deadline to Feb 29, 2024.
- Evofem's termination right for failure to receive Parent Loan extended to Feb 29, 2024.
- Joint Proxy Statement filing deadline moved from Feb 14 to April 1, 2024.

## SEC filing metadata
- accession: 0001213900-24-009659
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390024009659/0001213900-24-009659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390024009659/ea192759-8k425_aditxtinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-009659
- JSON: https://secwatch.observer/filing/0001213900-24-009659.json
- Plain text: https://secwatch.observer/filing/0001213900-24-009659.txt

## Key facts
- Material Agreements
  Aditxt, Inc. amended Second Amendment to Merger Agreement with Adicure, Inc. and Evofem Biosciences, Inc. (effective 2024-01-30).
  - Action: amendment
  - Agreement: merger
  - Counterparty: Adicure, Inc. and Evofem Biosciences, Inc.
  - Effective: 2024-01-30
  source text: On January 30, 2024, the Company, Adicure and Evofem entered into the Second Amendment to the Merger Agreement (the “ Second Amendment to Merger Agreement ”) to amend (i) the date of the Parent Loan (as defined in the Merger Agreement) to Evofem to be February 29, 2024, (ii) to change the date by which Evofem may terminate the Merger Agreement for failure to receive the Parent Loan to be February 29, 2024, and (iii) to change the filing date for the Joint Proxy Statement (as defined in the Merger Agreement) to April 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390024009659/0001213900-24-009659-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.